The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) databases were used to compare the expression of SIGLEC9. Then, we measured the expression of SIGLEC9 with immunohistochemical staining on 177 patients with gliomas to validate the results. This evidence concerns the gene SIGLEC9 and central nervous system cancer.